香港股市 已收市

Fresenius SE & Co. KGaA (FRE.DE)

XETRA - XETRA 延遲價格。貨幣為 EUR。
加入追蹤清單
27.21+0.03 (+0.11%)
收市:05:35PM CEST

Fresenius SE & Co. KGaA

Else-Kroener-Strasse 1
Bad Homburg vor der Höhe 61352
Germany
49 6172 6080
https://www.fresenius.com

版塊Healthcare
行業Medical Care Facilities
全職員工193,865

高階主管

名稱頭銜支付行使價出生年份
Mr. Michael SenCEO, President & Chairman of Management Board - Fresenius Management SE4.09M1968
Ms. Sara Lisa HennickenCFO & Member of the Management Board - Fresenius Management SE1.55M1980
Mr. Pierluigi AntonelliMember of Management Board of Fresenius Management SE & CEO of Fresenius Kabi2M
Dr. Michael Sven Moser Ph.D.Member of Management Board of Fresenius Management SE1.2M1978
Mr. Robert MollerMember of the Management Board of Fresenius Management SE1.15M1971
Mr. Markus GeorgiSenior Vice President of Investor Relations
Matthias LinkSenior Vice President Corporate Communications
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

公司管治

截至 2024年4月1日 止,Fresenius SE & Co. KGaA 的 ISS 管治質素評分為 2。 Pillar 分數正在審核中:1;董事會:3;股東權利:1;現金賠償:2。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。